NCT04975347View on ClinicalTrials.gov

Opioid Antagonism in Individuals Ascertained Through the Partners HealthCare Biobank

PHASE1Enrolling by invitationINTERVENTIONAL

Enrollment

49

Participants

Timeline

Start Date

June 3, 2022

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions

Reproductive Disorders

Interventions

DRUG

Naloxone

One bolus and one infusion of naloxone

Trial Locations (1)

02114

Massachusetts General Hospital, Boston

All Listed Sponsors

lead

Stephanie B. Seminara, MD

OTHER